Simultaneous Occurrence of ImmuneMediated Thrombocytopenia and Myocarditis After mRNA-1273COVID-19 Vaccination: A Case Report
10.3346/jkms.2022.37.e169
- Author:
Dae-Hwan BAE
1
;
Min KIM
;
Dae In LEE
;
Ju-Hee LEE
;
Sangmin KIM
;
Sang Yeub LEE
;
Jang-Whan BAE
;
Kyung-Kuk HWANG
;
Dong-Woon KIM
;
Myeong-Chan CHO
Author Information
1. Regional Cardiovascular Disease Center, Chungbuk National University Hospital, Cheongju, Korea
- Publication Type:Case Report
- From:Journal of Korean Medical Science
2022;37(21):e169-
- CountryRepublic of Korea
- Language:English
-
Abstract:
With the global spread of severe acute respiratory syndrome coronavirus 2, several vaccines were developed; messenger RNA (mRNA) vaccines have recently been widely used worldwide. However, the incidence of myocarditis following mRNA vaccination is increasing;although the cause of myocarditis has not yet been clearly identified, it is presumed to be caused by a problem in the innate immune system. Immune-mediated thrombocytopenia (ITP) after vaccination is rare but has been reported and is also assumed to occur by the same mechanism. We report the first case of simultaneous myocarditis and ITP after mRNA vaccination. A 38-year-old woman presented with chest pain, mild dyspnea, and sweating after vaccination with mRNA-1273 vaccine (Moderna) 4 days prior to admission.Upon admission to the emergency department, cardiac enzymes were elevated; blood test performed 5 months ago showed normal platelet count, but severe thrombocytopenia was observed upon admission. After administration of intravenous immunoglobulin, the platelet count improved; subsequently, myocarditis was observed on endomyocardial biopsy. Thus, myocarditis and ITP were judged to have occurred simultaneously due to the expression of the innate immune system markers after mRNA vaccination. The patient was discharged on day 6 of admission.
